Author

E. R. Rhodes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1 Research Focus:protein structure prediction· 1 Research Focus:sequence-to-function modeling· 1

Frequent Co-Authors

T. A. Whitehead· 3 shared B. M. Petersen· 2 shared M. Kirby· 2 shared P. J. Steiner· 2 shared A. Walker· 1 shared B. J. Dekosky· 1 shared C. Haas· 1 shared C. M. Haas· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

T. A. Whitehead

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An integrated technology for quantitative wide mutational scanning of human antibody Fab libraries

B. M. Petersen, M. Kirby, K. Chrispens, O. Irvin, I. Strawn, C. Haas, A. Walker, Z. T. Baumer, S. Ulmer, E. Ayala, O. Irvin, E. R. Rhodes, J. Guthmiller, P. J. Steiner, T. A. Whitehead

The paper introduces MAGMA-seq, a technology for quantitative analysis of antibody sequence-function relationships, demonstrating its application in mapping antibody development pathways and identifying binding determinants.

Nature Communications · May 10, 2024Peer-reviewedBiochemistry

Regulatory approved monoclonal antibodies contain framework mutations predicted from human antibody repertoires

B. M. Petersen, S. A. Ulmer, E. R. Rhodes, M. F. Gutierrez Gonzalez, B. J. Dekosky, K. G. Sprenger, T. A. Whitehead

The paper predicts framework mutations in therapeutic monoclonal antibodies using natural human antibody repertoires, showing potential to improve antibody properties and reduce immunogenicity.

bioRxiv · Jun 22, 2021Immunology

One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

I. Francino Urdaniz, P. J. Steiner, M. Kirby, F. Zhao, C. M. Haas, S. Barman, E. R. Rhodes, L. Peng, K. Sprenger, J. Jardine, T. A. Whitehead

The paper presents a method to identify SARS-CoV-2 Spike RBD escape mutants using yeast screening and provides associated resources.

bioRxiv · Mar 15, 2021Biochemistry